Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-20-042318
Filing Date
2020-07-13
Accepted
2020-07-13 19:00:21
Documents
1
Period of Report
2020-07-09

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3905
  Complete submission text file 0001209191-20-042318.txt   5279
Mailing Address 6310 NANCY RIDGE DRIVE SUITE 101 SAN DIEGO CA 92121
Business Address
Schmid John P. (Reporting) CIK: 0001478916 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-39376 | Film No.: 201026050

Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Issuer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)